Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92121


Purpose:

This study is designed to compare 2 doses of APD125 (20 mg and 40 mg) with placebo in otherwise healthy adults with primary insomnia primarily with complaints of maintaining sleep. Participants will be required to maintain a daily sleep dairy for up to 3 weeks while on study.


Criteria:

Inclusion Criteria: - Men and women, ages 18 to 65 years - Primary insomnia as defined in DSM-IV-TR, with predominant complaint of impaired sleep maintenance and confirmed by patient reported sleep diaries - Generally good health Exclusion Criteria: - History of any sleep disorder, other than primary insomnia (e.g., restless leg syndrome, narcolepsy, sleep apnea, and disorders of REM/NREM sleep) - Any clinically significant medical condition, laboratory finding, or ECG finding - Pregnant and/or lactating females - History of substance abuse within 2 years or positive urine drug screen - Positive Hepatitis B/C results or HIV markers - History of treatment with an investigational drug within the last month - Recent travel involving crossing more than 3 time zones or plans to travel to another time zone (> 3 time zones) during the study


NCT ID:

NCT00664664


Primary Contact:

Principal Investigator
Emil Chuang, MD
Arena Pharmaceuticals


Backup Contact:

N/A


Location Contact:

San Diego, California 92121
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.